From: MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K/AKT signaling pathway
Characteristics | n = 58 | miR-125 | P value | |
---|---|---|---|---|
High (n = 28) | Low (n = 30) | |||
Age (years) | 0.621 | |||
≥ 45 | 33 | 15 | 18 | |
< 45 | 25 | 13 | 12 | |
HPV 16/18 infection | 0.301 | |||
Positive | 41 | 18 | 23 | |
Negative | 17 | 10 | 7 | |
Tumor size | 0.031* | |||
< 4 cm | 25 | 8 | 17 | |
≥ 4 cm | 33 | 20 | 13 | |
Histology | 0.397 | |||
Squamous cell cancer | 24 | 10 | 14 | |
Adenocarcinima and others | 34 | 18 | 16 | |
Differentiation | 0.061 | |||
Well and moderately | 40 | 16 | 24 | |
Poor | 18 | 12 | 6 | |
FIGO | 0.018* | |||
I | 36 | 13 | 23 | |
II | 22 | 15 | 7 | |
Lymph node metastasis | 0.923 | |||
Negative | 39 | 19 | 20 | |
Positive | 19 | 9 | 10 |